Ganglion cell loss in relation to visual disability in multiple sclerosis. - Wikidata - awgldk - TriplyDB

Ganglion cell loss in relation to visual disability in multiple sclerosis.

Ganglion cell loss in relation to visual disability in multiple sclerosis.

http://www.wikidata.org/entity/Q36781704

about

Acute optic neuritis: Unmet clinical needs and model for new therapies OCT: New perspectives in neuro-ophthalmology Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases Remaining visual field and preserved subjective visual functioning prevent mental distress in patients with visual field defects Retinal neurodegeneration in Wilson's disease revealed by spectral domain optical coherence tomography.Deimination restores inner retinal visual function in murine demyelinating disease.Optical coherence tomography as a biomarker in multiple sclerosis.Vision and vision-related outcome measures in multiple sclerosis.Imaging as an Outcome Measure in Multiple Sclerosis.Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis.Outcome Measures in Clinical Trials for Multiple Sclerosis.Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.Comparison of spectral-domain optical coherence tomography for intra-retinal layers thickness measurements between healthy and diabetic eyes among Chinese adults Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.Dynamic visual tests to identify and quantify visual damage and repair following demyelination in optic neuritis patients.Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.Functional-structural correlations in the afferent visual pathway in pediatric demyelination.Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis One-year follow-up of macular ganglion cell layer and peripapillary retinal nerve fibre layer thickness changes after panretinal photocoagulation.Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life An Eye on Brain Integrity: Acute Optic Neuritis Affects Resting State Functional Connectivity.Applications of optical coherence tomography in pediatric clinical neuroscience.Reliability of Intra-Retinal Layer Thickness Estimates.Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.Retinal nerve fiber layer thickness in prematurity is correlated with stage of retinopathy of prematurity.Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.Retinal Ganglion Cell Layer Thinning Within One Month of Presentation for Non-Arteritic Anterior Ischemic Optic Neuropathy.Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension.Outer retinal changes following acute optic neuritis.Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.

P2860

Q26799784-1A3CBDB5-7773-42DC-B4FB-80AAC763D97D Q27009498-6CADF4B9-8A12-4379-BBC5-5B4D67047380 Q28076588-4CE55EDA-8B29-48EE-8D90-03E5DC12DB4E Q28080265-5FAEF959-4869-48D9-8811-5D8A3B3ABAF9 Q30448989-C85CDE3B-C3F1-44E0-9F78-488BF8413AD3 Q30460735-554A26A6-A17F-4B55-9232-B4713C84972F Q30533881-19984656-BED7-461A-96CB-116F9C8B6504 Q30597564-0C55D9FA-DBA6-453C-90AE-2046C081FD7E Q30872452-D5FD14C3-38F5-4F84-A973-BD8F0EDFC7CD Q31134617-6090CA9C-9656-4692-8CA9-D4ABA279FFFB Q31140679-62E39438-35D8-466A-8146-89CA225A5BA5 Q31160866-E00DF4C7-E94C-4719-B542-0C2C5EBABCF3 Q31162456-7AE528BC-6B50-49B9-8A3D-0CC75CEAE9F2 Q33664188-B0EB7A35-10B3-4132-8D43-1C9AF2E73B74 Q34076168-BC129C9B-2C5F-400C-914A-6D64E7325907 Q34211912-9FD3A4A6-1846-471C-A92B-A2ADF96623DC Q34278880-846F3D92-9F4F-4BE5-B9A7-B62170EB573A Q34734582-AAAF0D87-E34A-419D-BFC8-2D9869E9F342 Q34771237-E29BF469-80E0-4288-A605-66F3801041BF Q34785270-9F4A1FEC-6B4C-401F-B747-1E5216B2492A Q34991161-692C28F5-1FEE-4C81-83B2-DA0BB73279FD Q34992546-0C9A1757-C3B3-4416-BB22-489A0550B4E9 Q35047832-DDF8D83B-037C-4AB4-B40B-0AE60200EE33 Q35066822-8C023F89-02A3-4F96-AFAA-DFB5E8E539C8 Q35098877-3D349385-6CDF-4E00-A4CE-7E5CDA02A5AF Q35111163-221AC1FC-F80B-4737-83BC-FE5CB94C713B Q35560008-8828F4B9-6554-431D-AC08-CBD06114CB89 Q35620366-246EF0D6-A019-4C04-911B-BA42C5B4901D Q35766939-197EE10A-ADCB-4BBF-BB69-7085DC8878BF Q35771457-19309A4A-038A-4107-85B8-3BCFC20B9BCD Q35786892-9861A73A-B80D-4E83-9FA4-D230D020D518 Q35836853-9FD97EEC-74C4-4057-B070-64690B8AD5C7 Q36058632-AE71FF6B-7092-4ECB-87B3-9CAA26B7D36E Q36063052-31699BC6-D649-48C9-AEFB-C1E71134A6A5 Q36070021-A5C4B7F7-5FF0-4332-A003-2DE4876B1D77 Q36327952-E6D8374B-AB89-4ADE-894D-AAE77B5E11DA Q36420646-0A4D3DE3-9770-4264-88AF-62847B579CEC Q36495226-7041959F-0BC5-46C4-B626-5D935CEF5B85 Q36496806-96A2EB54-7349-4ABB-8EFC-2A1CB709FFA0 Q36511714-7BEF9D61-3589-45DF-A12B-899BFD7FA3B5

P2860

Ganglion cell loss in relation to visual disability in multiple sclerosis.

http://www.wikidata.org/entity/Q36781704

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Ganglion cell loss in relation to visual disability in multiple sclerosis.

@en

type

label

Ganglion cell loss in relation to visual disability in multiple sclerosis.

@en

prefLabel

Ganglion cell loss in relation to visual disability in multiple sclerosis.

@en

P1433

Q36781704-159C43D2-9F8E-426B-B5DF-A27AD0059AEF

P1476

Q36781704-0BA3C2F5-5C98-42F4-B79D-AFB161591C4E

P2093

Q36781704-300ED312-DFB3-425E-B3AC-110D64917A11

Q36781704-4D2DF493-387D-4D84-AC78-06D443941666

Q36781704-7EF57892-5816-4B46-8422-61E93CEF8B5F

Q36781704-9655132F-1471-461E-B703-E9B9C7A551A8

Q36781704-A0C84412-63B4-44B9-B77C-DD2F537E4B64

Q36781704-A4FF0B44-38BC-4289-AC74-733B37747672

Q36781704-BDA39304-2F3D-45B0-B9EB-B8133BF3162D

Q36781704-E0B468BB-1A34-4BF5-AB40-061CEBF9AE2F

Q36781704-EAB7ABF9-B257-4E5A-950B-3BABB2BD7403

Q36781704-F4CC7338-24BC-44F9-BB84-7824A65C28BF

P2860

Q36781704-092E9CE0-7839-4916-90A6-B78FAFEE45A0

Q36781704-0B147F6A-C675-495B-A69A-89B44D298B03

Q36781704-0C35E423-2BA9-4735-B4B9-6DAA22F58639

Q36781704-1028B20D-5F14-490D-A8C8-EA0E64B6292D

Q36781704-25818D76-6BD6-496C-8444-7F2D288268F7

Q36781704-3099AE9C-49D5-4F0D-925E-FA8E22A243AE

Q36781704-35990943-36DA-4BE6-AE36-AE5FA89F9A1F

Q36781704-39D614B1-89B6-4A2A-B9BC-6B5037692644

Q36781704-3A2F127A-F593-405E-8F15-04C0B3D432C9

Q36781704-4969CF7C-A59B-4EE8-8E4F-F46C315A6580

P304

Q36781704-2E163344-39EE-4A97-B3B8-ED7989556601

P31

Q36781704-8AC298B1-D06F-4834-9EC4-0E7C3BBC1D62

P356

Q36781704-4972CAA2-97CC-4200-AF41-E1CC953FCDAE

P433

Q36781704-3F87ED51-2CED-463D-B04B-53184CC57C61

P478

Q36781704-125B5EBD-41D0-44AB-80AE-5AD5873C938A

P50

Q36781704-C54D1D98-CC13-4310-8233-84B077C72275

Q36781704-C8E44817-6D4F-4576-A49E-A7383523E54B

Q36781704-D815936A-0788-4759-9763-F8A19FBED3B9

P577

Q36781704-016A6C21-5AE9-4A16-AC7A-7E8378D10CAD

P5875

Q36781704-5F729799-7DFE-4644-AC80-50973F07B8FD

P698

Q36781704-C5CDCCEE-6533-4508-8A45-0F87F99C41EB

P921

Q36781704-3933735D-D93D-465D-845C-CC79FC0D43DC

Q36781704-554FB7BF-F885-4FC2-8BE7-680E418A0FB7

P932

Q36781704-172B0B28-A8E8-461C-B5E0-4A7DF1AA8559

P356

J.OPHTHA.2011.11.032

P1433

P1476

Ganglion cell loss in relation to visual disability in multiple sclerosis.

@en

P2093

Daniel J Feller

http://www.w3.org/2001/XMLSchema#string

Elliot Frohman

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ishikawa

http://www.w3.org/2001/XMLSchema#string

James A Wilson

http://www.w3.org/2001/XMLSchema#string

Joel S Schuman

http://www.w3.org/2001/XMLSchema#string

Kristin M Galetta

http://www.w3.org/2001/XMLSchema#string

Maureen G Maguire

http://www.w3.org/2001/XMLSchema#string

Reiko E Sakai

http://www.w3.org/2001/XMLSchema#string

Sam B Henderson

http://www.w3.org/2001/XMLSchema#string

Scott D Walter

http://www.w3.org/2001/XMLSchema#string

P2860

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness.

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Macular segmentation with optical coherence tomography

Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis

Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.

Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.

Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis.

A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions.

P304

1250-1257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2011.11.032

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Peter A Calabresi

P577

2012-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221861286

http://www.w3.org/2001/XMLSchema#string

P698

22365058

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3631566

http://www.w3.org/2001/XMLSchema#string